BioXcel Therapeutics, Inc.

/BioXcel Therapeutics, Inc.


BioXcel Therapeutics, Inc.

They are a clinical stage biopharmaceutical company focused on drug development that utilizes novel artificial intelligence, or AI, to identify the next wave of medicines across neuroscience and immuno-oncology.



Price Range
$11.00 - $13.00

Final Shares

Effective Date
March 8, 2018

Barclays, UBS Investment Bank, BMO Capital Markets

To view the prospectus for BioXcel Therapeutics, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange